GlobeNewswire

StackPath and Server Density Merge

Dela

Brings Industry-Leading Monitoring to StackPath's Secure Edge Services Platform

 

DALLAS, May 14, 2018 (GLOBE NEWSWIRE) -- Server Density, a provider of proactive infrastructure monitoring for cloud, servers, and websites, is merging with StackPath, a leading secure edge services platform provider. Server Density enables users to monitor their websites and servers in the cloud or on-prem from a single console and API to easily diagnose problems, maintain uptime and maximize server performance. The service will be integrated and offered as part of the StackPath platform in the very near future.

"We're thrilled to have Server Density become part of our company. It's a perfect fit," said Lance Crosby, founder, chairman and CEO of StackPath. "StackPath has the highest commitment to providing our customers frictionless services, complete visibility into their solutions, and building strong relationships with the open source community and the industry at large. Server Density has followed the same commitments as it built exceptional technologies that are second to none and grew operations at cloud scale."

The Server Density monitoring agent is installed on millions of servers, collecting more than 12-billion metrics each day. The service has more than 100 official integrations with other solutions and platforms, processes more than 300TB of data per month and has availability probes in more than 28 different geographies. Its 1,000+ customers across 75 different countries span all sizes and industries, such as and including the UK's National Health Service (NHS), eCommerce company Firebox, and online game platform Stormancer.

"We created Server Density out of the frustration that monitoring tools were either too expensive, too complex, or both," David Mytton, Server Density co-founder and CEO said. "It's gratifying to see how well our tools have been received, not only by customers, but by developers and companies that have built on the code that we've open sourced. My team and I are excited to bring Server Density into the StackPath platform and accelerate even more evolutionary ways to leverage these technologies."

In addition to its monitoring service, in 2016 Server Density created HumanOps a community that gets people talking about the human aspects of running infrastructure. Companies such as Spotify, PagerDuty, Yelp and Facebook have contributed to sharing ideas and best practices for life on call, dealing with technical debt, fatigue and stress at events around the world, including the UK, US, France, Germany, Poland and more.

"HumanOps is a brilliant and long overdue resource for cloud workers and companies. This industry is evolving faster than any before it, requiring operations of unprecedented scale and solutions at unbelievable speed," said Mr. Crosby. "It takes its toll on people-humans don't have a 100% uptime SLA. We're looking forward to doing even more with HumanOps as part of StackPath."

In December 2015, Server Density raised $1.5 million in seed funding led by SP Ventures. They previously had raised €50k from Seedcamp and funding from angel investors Christoph Janz, Dick Williams, Qamar Aziz, and others. Financial details of the transaction are not being disclosed. Moving forward, the Server Density team in London will serve as the core of StackPath monitoring service team and London will become StackPath's European headquarters.

About StackPath
StackPath is a platform of secure internet services including CDNWAF and DDoS mitigation built at the cloud's edge. StackPath services enable developers at organizations of any size to build protection and performance into any cloud-based solution-from SaaS to web publishing, gaming, media streaming and beyond-without needing cloud security and delivery expertise of their own. More than one million customers, ranging from early-stage companies to Fortune 100 organizations, use StackPath services. Headquartered in Dallas, Texas, StackPath has offices across the U.S. and around the world. For more information, visit stackpath.com and follow StackPath at www.fb.com/stackpathllc and www.twitter.com/stackpath.

About Server Density
Server Density offers SaaS-based scalable infrastructure monitoring to help businesses save time and money. With advanced server and website monitoring alerts, graphing tools and integrations with all major cloud service providers, Server Density's robust and scalable solution helps businesses and IT operations teams be more responsive to issues, make their websites faster and minimize downtime. Founded by David Mytton in 2009 and based in London, Server Density monitors mission critical IT infrastructure for more than 1,000 customers.

For more information, media and analysts may contact
Susie McDonald
StackPath
VP Corporate Communications
susan.mcdonald@stackpath.com 
503-806-3841




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: StackPath via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development delays publication of its Annual Report for 2018 and changes date for the Annual General Meeting26.4.2019 08:00:00 CESTPressmeddelande

STOCKHOLM, SWEDEN - 26 April 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that The Board of Directors has decided to delay the publication of its Annual Report for 2018. Karolinska Development has changed the date for the Annual General Meeting to June 26, 2019. The date for publication of the Annual Report for 2018 has been changed from April 26 to April 30, 2019. Karolinska Development has changed the date for the Annual General Meeting from June 4 to June 26, 2019. Notice to the Annual General Meeting will be published in a separate press release. For more information, please contact: Viktor Drvota, CEO, Karolinska Development AB Phone: +46 73 982 52 02, e-mail: viktor.drvota@karolinskadevelopment.com Fredrik Järrsten, CFO, Karolinska Development AB Phone: +46 70 496 46 28, e-mail: fredrik.jarrsten@karolinskadevelopment.com TO THE EDITORS About Karolinska Development AB Karolinska Development AB (Nasdaq Stockholm: KDEV) is a Nordic life sciences investmen

Karolinska Development senarelägger publicering av årsredovisningen för 2018 och meddelar nytt datum för årsstämma26.4.2019 08:00:00 CESTPressmeddelande

STOCKHOLM, SVERIGE - 26 april 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att styrelsen har beslutat att senarelägga publiceringen av årsredovisningen för 2018. Karolinska Development har ändrat datum för årsstämman till den 26 juni 2019. Publiceringen av årsredovisningen för 2018 flyttas från den 26 april till den 30 april 2019. Karolinska Development har ändrat datum för årsstämman från den 4 juni till den 26 juni 2019. Kallelse till årsstämman kommer att publiceras senare i ett separat pressmeddelande. För ytterligare information, vänligen kontakta: Viktor Drvota, vd, Karolinska Development AB Tel: +46 73 982 52 02, e-mail: viktor.drvota@karolinskadevelopment.com Fredrik Järrsten, finanschef, Karolinska Development AB Tel: +46 70 496 46 28, e-mail: fredrik.jarrsten@karolinskadevelopment.com TILL REDAKTÖRERNA Om Karolinska Development AB Karolinska Development AB (Nasdaq Stockholm: KDEV) är ett nordiskt investmentbolag inom life science. Bolaget fokuserar p

Karolinska Developments portföljbolag Aprea Therapeutics har fått särläkemedelsstatus och snabbspårstatus från FDA för APR-24616.4.2019 12:46:00 CESTPressmeddelande

STOCKHOLM, SVERIGE - 16 april 2019. Karolinska Development AB meddelar idag att portföljbolaget Aprea Therapeutics har av FDA fått särläkemedelsstatus för APR-246 för behandling av patienter med TP53-muterad myelodysplastiskt syndrom (MDS). Dessutom ger FDA bolaget snabbspårstatus (Fast Track Designation), för APR-246 för behandling av MDS. Amerikanska läkemedelsverket, FDA, ger särläkemedelsstatus till läkemedelskandidater för att snabba på utvärderingen och utvecklingen av säkra och effektiva behandlingar av ovanliga sjukdomar. Särläkemedelsstatus ger företag både regulatoriska och kommersiella incitament genom att läkemedlet får marknadsexklusivitet på den amerikanska marknaden i sju år efter marknadsgodkännande samtidigt som företaget får stöd från FDA när det gäller designen av kliniska prövningar, skatteförmåner för kostnader kopplade till kliniska prövningar och avgiftsbefrielse från FDA. FDA:s snabbspår underlättar utvecklingen av läkemedel som är avsedda för att behandla allva

Karolinska Development's portfolio company Aprea Therapeutics has received FDA Orphan Drug Designation and Fast Track Designation for APR-24616.4.2019 12:46:00 CESTPressmeddelande

STOCKHOLM, April 16, 2019. Karolinska Development's portfolio company Aprea Therapeutics has from FDA received an Orphan Drug Designation for APR-246 for the treatment of patients with Myelodysplastic Syndromes (MDS) having a TP53 mutation. In addition, FDA has also granted Fast Track Designation to APR-246 for treatment of MDS. Orphan Drug Designation is granted by the FDA Office of Orphan Products Development to advance the evaluation and development of safe and effective therapies for the treatment of rare diseases. The designation can provide development and commercial incentives for designated compounds and medicines, including eligibility for a seven-year period of market exclusivity in the U.S. after product approval, FDA assistance in clinical trial design, tax credits related to clinical trial expenses, and an exemption from FDA user fees. The FDA's Fast Track program facilitates the development of drugs intended to treat serious conditions and that have the potential to addre

Bergman & Beving AB: Bergman & Beving förvärvar KGC10.4.2019 14:00:00 CESTPressmeddelande

Pressmeddelande Bergman & Beving förvärvar KGC Bergman & Beving har idag tecknat avtal om förvärv av samtliga aktier i KGC Verktyg & Maskiner AB. KGC, med säte i Älvsjö, har i mer än 60 år utvecklat och levererat kvalitetsverktyg och tillbehör för murning och plattsättning i det egna varumärket KGC. Bolaget omsätter cirka 80 MSEK per år, och har 24 anställda. "KGC är ett ledande varumärke med högt anseende hos murare och plattsättare och har en mycket stark ställning på den svenska marknaden", säger Pontus Boman, VD och koncernchef. Tillträde beräknas ske den 1 maj 2019 och förvärvet bedöms ha en marginellt positiv påverkan på Bergman & Bevings resultat per aktie under innevarande räkenskapsår. Stockholm den 10 april 2019 Bergman & Beving AB (publ) För ytterligare information kontakta: Pontus Boman, VD & Koncernchef, telefon 010-454 77 00 Peter Schön, CFO, telefon 070-339 89 99 Denna information lämnades, genom ovanstående kontaktpersoners försorg, för offentliggörande den 10 april 201

Bergman & Beving AB: Bergman & Beving acquires KGC10.4.2019 14:00:00 CESTPressmeddelande

Press release Bergman & Beving acquires KGC Bergman & Beving has today signed an agreement to acquire all shares in KGC Verktyg & Maskiner AB. KGC, based in Älvsjö, has for more than 60 years developed and delivered quality tools and accessories for bricklayers and tilers in its own brand KGC. The business has a turnover of approximately SEK 80 million per year, and has 24 employees. "KGC is a leading brand with high reputation among bricklayers and tilers and has a very strong position in the Swedish market," says Pontus Boman, President and CEO. The closing is taking effect on 1 May 2019 and the acquisition is expected to have a marginal positive impact on Bergman & Beving's earnings per share during the current fiscal year. Stockholm, 10 April 2019 Bergman & Beving AB (publ) For further information, please contact: Pontus Boman, President & CEO, Tel: +46 10 454 77 00 Peter Schön, CFO, Tel: +46 70 339 89 99 The information was submitted for publication, through the agency of the cont

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum